174 related articles for article (PubMed ID: 1851452)
1. Effect of hypothalamic norepinephrine depletion on median eminence CRF-41 content and serum ACTH in control and adrenalectomized rats.
Weidenfeld J; Feldman S
Brain Res; 1991 Mar; 542(2):201-4. PubMed ID: 1851452
[TBL] [Abstract][Full Text] [Related]
2. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic norepinephrine depletion inhibits CRF-41 release following neural stimuli.
Feldman S; Weidenfeld J
Neuroreport; 1993 Dec; 5(3):258-60. PubMed ID: 8298085
[TBL] [Abstract][Full Text] [Related]
4. The adrenocorticotropin response to interleukin-1 beta instilled into the rat median eminence depends on the local release of catecholamines.
Matta S; Singh J; Newton R; Sharp BM
Endocrinology; 1990 Nov; 127(5):2175-82. PubMed ID: 2171909
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive corticotropin-releasing factor in rat plasma.
Sumitomo T; Suda T; Tomori N; Yajima F; Nakagami Y; Ushiyama T; Demura H; Shizume K
Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
[TBL] [Abstract][Full Text] [Related]
6. Central catecholaminergic system stimulates secretion of CRH at different sites.
Szafarczyk A; Guillaume V; Conte-Devolx B; Alonso G; Malaval F; Pares-Herbuté N; Oliver C; Assenmacher I
Am J Physiol; 1988 Oct; 255(4 Pt 1):E463-8. PubMed ID: 2845801
[TBL] [Abstract][Full Text] [Related]
7. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity.
Berkenbosch F; Tilders FJ
Brain Res; 1988 Mar; 442(2):312-20. PubMed ID: 2453250
[TBL] [Abstract][Full Text] [Related]
8. Effects of bilateral adrenalectomy on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.
Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
Endocrinology; 1983 Sep; 113(3):1182-4. PubMed ID: 6307668
[TBL] [Abstract][Full Text] [Related]
9. Central administration of alpha-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release in adrenalectomized rats.
Tozawa F; Suda T; Dobashi I; Ohmori N; Kasagi Y; Demura H
Neurosci Lett; 1994 Jun; 174(1):117-9. PubMed ID: 7970145
[TBL] [Abstract][Full Text] [Related]
10. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
Plotsky PM; Sawchenko PE
Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T
Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission.
Haas DA; George SR
Brain Res; 1989 Oct; 498(2):333-8. PubMed ID: 2551461
[TBL] [Abstract][Full Text] [Related]
13. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats.
Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352
[TBL] [Abstract][Full Text] [Related]
14. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
[TBL] [Abstract][Full Text] [Related]
15. The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.
Guillaume V; Conte-Devolx B; Szafarczyk A; Malaval F; Pares-Herbute N; Grino M; Alonso G; Assenmacher I; Oliver C
Neuroendocrinology; 1987 Aug; 46(2):143-6. PubMed ID: 2819759
[TBL] [Abstract][Full Text] [Related]
16. Involvement of vasopressin in the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy.
Holmes MC; Catt KJ; Aguilera G
Endocrinology; 1987 Dec; 121(6):2093-8. PubMed ID: 2824180
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis.
Wohlman A; Gallily R; Yirmiya R; Weidenfeld J
Neuroendocrinology; 1997 Sep; 66(3):221-8. PubMed ID: 9380280
[TBL] [Abstract][Full Text] [Related]
18. Regulation of corticotropin-releasing hormone and pituitary-adrenocortical response during acute and repeated stress in the rat.
Culman J; Kopin IJ; Saavedra JM
Endocr Regul; 1991 Sep; 25(3):151-8. PubMed ID: 1662551
[TBL] [Abstract][Full Text] [Related]
19. Corticosterone-induced changes in hypothalamic corticotropin-releasing factor (CRF) content after stress.
Sato T; Sato M; Shinsako J; Dallman MF
Endocrinology; 1975 Aug; 97(2):265-74. PubMed ID: 169120
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic CRF-like immunoreactivity in the rat after hypophysectomy or adrenalectomy.
Moldow RL; Fischman AJ
Peptides; 1982; 3(2):143-7. PubMed ID: 6285319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
